Obtain the data you need to make the most informed decisions by accessing our extensive portfolio of information, analytics, and expertise. Sign in to the product or service center of your choice.
Customer Logins
Eóin Ryan is a senior analyst within the life sciences group at IHS Markit, covering the European region.
Life Sciences Irish green credentials fail on pharmaceutical waste exports 02 August 2019 Eoin Ryan Foreign investment in Ireland's pharmaceutical...
Life Sciences Accuracy check: Norwegian health expenditure data 29 March 2019 Eoin Ryan The recent publication of Norway's Statistik Sentralbyrå...
Life Sciences Humira faces up to intense biosimilar competition 28 November 2018 Eoin Ryan Praful Mehta The early signs of biosimilar competition...
Life Sciences Italian pharma tendering set for new oversight in two-year outlook 08 October 2018 Eoin Ryan Italy's public procurement agency...
Life Sciences Norwegian pharma industry calls for tendering and IRP reforms 05 October 2018 Eoin Ryan The pharmaceutical sector in Norway has...
Life Sciences UK post-Brexit participation in unified patent court poses plenty of questions 28 September 2018 Eoin Ryan The UK's future eligibility...
Life Sciences On the road to HTA harmonization in Europe 28 February 2018 Eoin Ryan Last month’s proposals by the European Commission for the...
Life Sciences Amsterdam triumphs: Is the Netherlands a Trojan horse for pricing and drug approval reform in Europe? 28 November 2017 Eoin Ryan...
Life Sciences Nordics inch toward cooperation on drug purchasing, but don't expect early developments 13 April 2017 Eoin Ryan In late March...
Life Sciences Deepening European ties: A look at the potential impact of recent IRP changes in Ireland 09 September 2016 Eoin Ryan For any of...
Gustav Ando
Executive Director, Life Sciences, IHS Markit
Milena Izmirlieva
Director, Life Sciences Research, IHS Markit
Tim Dall
Managing Director - Consulting, Life Sciences, Economics and Country Risk, IHS Markit